These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 28385672)

  • 1. Characterization of health care utilization in patients receiving implantable cardioverter-defibrillator therapies: An analysis of the managed ventricular pacing trial.
    Rickard J; Whellen D; Sherfesee L; Peterson BJ; Nahey T; Tang AS; Ellenbogen KA; Cheng A
    Heart Rhythm; 2017 Sep; 14(9):1382-1387. PubMed ID: 28385672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of long-detection interval vs standard-detection interval for implantable cardioverter-defibrillators on antitachycardia pacing and shock delivery: the ADVANCE III randomized clinical trial.
    Gasparini M; Proclemer A; Klersy C; Kloppe A; Lunati M; Ferrer JB; Hersi A; Gulaj M; Wijfels MC; Santi E; Manotta L; Arenal A
    JAMA; 2013 May; 309(18):1903-11. PubMed ID: 23652522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of defibrillator therapy in catecholaminergic polymorphic ventricular tachycardia.
    Roses-Noguer F; Jarman JW; Clague JR; Till J
    Heart Rhythm; 2014 Jan; 11(1):58-66. PubMed ID: 24120999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized study to compare ramp versus burst antitachycardia pacing therapies to treat fast ventricular tachyarrhythmias in patients with implantable cardioverter defibrillators: the PITAGORA ICD trial.
    Gulizia MM; Piraino L; Scherillo M; Puntrello C; Vasco C; Scianaro MC; Mascia F; Pensabene O; Giglia S; Chiarandà G; Vaccaro I; Mangiameli S; Corrao D; Santi E; Grammatico A;
    Circ Arrhythm Electrophysiol; 2009 Apr; 2(2):146-53. PubMed ID: 19808459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in effects of electrical therapy type for ventricular arrhythmias on mortality in implantable cardioverter-defibrillator patients.
    Sweeney MO; Sherfesee L; DeGroot PJ; Wathen MS; Wilkoff BL
    Heart Rhythm; 2010 Mar; 7(3):353-60. PubMed ID: 20185109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased Hospitalizations and Overall Healthcare Utilization in Patients Receiving Implantable Cardioverter-Defibrillator Shocks Compared With Antitachycardia Pacing.
    Sanders P; Connolly AT; Nabutovsky Y; Fischer A; Saeed M
    JACC Clin Electrophysiol; 2018 Feb; 4(2):243-253. PubMed ID: 29749945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and Safety of Appropriate Shocks and Antitachycardia Pacing in Transvenous and Subcutaneous Implantable Defibrillators: Analysis of All Appropriate Therapy in the PRAETORIAN Trial.
    Knops RE; van der Stuijt W; Delnoy PPHM; Boersma LVA; Kuschyk J; El-Chami MF; Bonnemeier H; Behr ER; Brouwer TF; Kääb S; Mittal S; Quast ABE; Smeding L; Tijssen JGP; Bijsterveld NR; Richter S; Brouwer MA; de Groot JR; Kooiman KM; Lambiase PD; Neuzil P; Vernooy K; Alings M; Betts TR; Bracke FALE; Burke MC; de Jong JSSG; Wright DJ; Jansen WPJ; Whinnet ZI; Nordbeck P; Knaut M; Philbert BT; van Opstal JM; Chicos AB; Allaart CP; Borger van der Burg AE; Clancy JF; Dizon JM; Miller MA; Nemirovsky D; Surber R; Upadhyay GA; Weiss R; de Weger A; Wilde AAM; Olde Nordkamp LRA;
    Circulation; 2022 Feb; 145(5):321-329. PubMed ID: 34779221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical course and prognostic relevance of antitachycardia pacing-terminated ventricular tachyarrhythmias in implantable cardioverter-defibrillator patients.
    Kleemann T; Strauss M; Kouraki K; Zahn R
    Europace; 2015 Jul; 17(7):1068-75. PubMed ID: 25687746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival after shock therapy in implantable cardioverter-defibrillator and cardiac resynchronization therapy-defibrillator recipients according to rhythm shocked. The ALTITUDE survival by rhythm study.
    Powell BD; Saxon LA; Boehmer JP; Day JD; Gilliam FR; Heidenreich PA; Jones PW; Rousseau MJ; Hayes DL
    J Am Coll Cardiol; 2013 Oct; 62(18):1674-1679. PubMed ID: 23810882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arrhythmic episodes in patients implanted with a cardioverter-defibrillator - results from the Prospective Study on Predictive Quality with Preferencing PainFree ATP therapies (4P).
    Regoli F; Graf D; Schaer B; Duru F; Ammann P; Stefano LMDS; Naegli B; Burri H; Zbinden R; Krasniqi N; Fromer M;
    BMC Cardiovasc Disord; 2019 Jun; 19(1):146. PubMed ID: 31208342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of ICD Therapies on Mortality in the OMNI Trial.
    Sun S; Johnson J; Degroot P; Brown ML; Obel O
    J Cardiovasc Electrophysiol; 2016 Feb; 27(2):192-9. PubMed ID: 26501695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Healthcare Utilization and Expenditures Associated With Appropriate and Inappropriate Implantable Defibrillator Shocks.
    Turakhia MP; Zweibel S; Swain AL; Mollenkopf SA; Reynolds MR
    Circ Cardiovasc Qual Outcomes; 2017 Feb; 10(2):. PubMed ID: 28196927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective randomized multicenter trial of empirical antitachycardia pacing versus shocks for spontaneous rapid ventricular tachycardia in patients with implantable cardioverter-defibrillators: Pacing Fast Ventricular Tachycardia Reduces Shock Therapies (PainFREE Rx II) trial results.
    Wathen MS; DeGroot PJ; Sweeney MO; Stark AJ; Otterness MF; Adkisson WO; Canby RC; Khalighi K; Machado C; Rubenstein DS; Volosin KJ;
    Circulation; 2004 Oct; 110(17):2591-6. PubMed ID: 15492306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Additional antitachycardia pacing programming strategies further reduce unnecessary implantable cardioverter-defibrillator shocks.
    Joung B; Lexcen DR; Ching CK; Silver MT; Piccini JP; Sterns LD; Rabinovich R; Pickett RA; Liu S; Brown ML; Cheng A
    Heart Rhythm; 2020 Jan; 17(1):98-105. PubMed ID: 31369873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arrhythmia rate distribution and tachyarrhythmia therapy in an ICD population: results from the INTRINSIC RV trial.
    Sullivan RM; Russo AM; Berg KC; Stolen KQ; Seth M; Perschbacher D; Day JD; Olshansky B
    Heart Rhythm; 2012 Mar; 9(3):351-8. PubMed ID: 22016074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of long detection interval implantable cardioverter-defibrillator settings in secondary prevention population: data from the Avoid Delivering Therapies for Nonsustained Arrhythmias in ICD Patients III (ADVANCE III) trial.
    Kloppe A; Proclemer A; Arenal A; Lunati M; Martìnez Ferrer JB; Hersi A; Gulaj M; Wijffels MC; Santi E; Manotta L; Mangoni L; Gasparini M
    Circulation; 2014 Jul; 130(4):308-14. PubMed ID: 24838360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High incidence of appropriate and inappropriate ICD therapies in children and adolescents with implantable cardioverter defibrillator.
    Korte T; Köditz H; Niehaus M; Paul T; Tebbenjohanns J
    Pacing Clin Electrophysiol; 2004 Jul; 27(7):924-32. PubMed ID: 15271011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitachycardia pacing reduces appropriate and inappropriate shocks in children and congenital heart disease patients.
    Kalra Y; Radbill AE; Johns JA; Fish FA; Kannankeril PJ
    Heart Rhythm; 2012 Nov; 9(11):1829-34. PubMed ID: 22766560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Programming antitachycardia pacing for primary prevention in patients with implantable cardioverter defibrillators: results from the PROVE trial.
    Saeed M; Neason CG; Razavi M; Chandiramani S; Alonso J; Natarajan S; Ip JH; Peress DF; Ramadas S; Massumi A
    J Cardiovasc Electrophysiol; 2010 Dec; 21(12):1349-54. PubMed ID: 20561107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shock Reduction With Multiple Bursts of Antitachycardia Pacing Therapies to Treat Fast Ventricular Tachyarrhythmias in Patients With Implantable Cardioverter Defibrillators: A Multicenter Study.
    Anguera I; Dallaglio P; Martínez-Ferrer J; Rodríguez A; Alzueta J; Pérez-Villacastín J; Porres JM; Viñolas X; Fontenla A; Fernández-Lozano I; García-Alberola A; Sabaté X
    J Cardiovasc Electrophysiol; 2015 Jul; 26(7):774-82. PubMed ID: 25916814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.